The company closed its plan on December 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.49 CNY | +0.14% | +0.11% | -12.37% |
May. 20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.37% | 1.63B | |
-3.15% | 89.69B | |
+3.95% | 41.34B | |
-10.51% | 33.72B | |
+58.94% | 26.11B | |
-20.09% | 14.63B | |
-8.92% | 12.84B | |
-11.46% | 11.66B | |
-43.05% | 11.52B | |
+5.32% | 8.92B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback announced on September 18, 2023, has closed with 2,251,804 shares, for CNY 74.8 million.